{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-025876","form_type":"8-K","ticker":"RKDA","cik":"0001469443","company_name":"Arcadia Biosciences, Inc.","filed_at":"2022-11-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.762249+00:00","generated_at":"2026-06-21T11:36:49.074870+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Arcadia Biosciences appoints Thomas Schaefer as CFO, succeeding Pamela Haley","bullets":["Pamela Haley resigns as CFO effective January 3, 2023; will stay in advisory role.","Thomas J. Schaefer, current VP of Finance and IR, promoted to CFO effective same date.","Schaefer has 20+ years finance experience, previously at Flavor Producers and Edward Jones, holds CFA.","Schaefer led commercial launch of GoodWheat and development of long-term strategy Project Greenfield."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-025876","json":"https://secwatch.observer/filing/0000950170-22-025876.json","markdown":"https://secwatch.observer/filing/0000950170-22-025876.md","text":"https://secwatch.observer/filing/0000950170-22-025876.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1469443/000095017022025876/0000950170-22-025876-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1469443/000095017022025876/rkda-20221128.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T11:36:49.074870+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4d81505dae","claim":"Pamela Haley resigned as chief financial officer at Arcadia Biosciences, Inc..","evidence_excerpt":"On November 28, 2022, Pamela Haley provided notice to Arcadia Biosciences, Inc. (“Arcadia”) of her resignation as Arcadia’s chief financial officer, effective as of January 3, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1469443/000095017022025876/0000950170-22-025876-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"chief financial officer"}],"fact_type":"executive_change"},{"claim_id":"6b9da72886","claim":"Thomas J. Schaefer was appointed as chief financial officer at Arcadia Biosciences, Inc..","evidence_excerpt":"On November 30, 2022 and effective January 3, 2022, Arcadia’s board of directors appointed Thomas J. Schaefer as Arcadia’s new chief financial officer to succeed Ms. Haley.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1469443/000095017022025876/0000950170-22-025876-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"chief financial officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}